Table 3.
Characteristic of study population at V2 (n = 24). Comparison between patients who suspended therapy after 1 month (FU group, n = 15) and patients who continued therapy for other 3 months (PT group). Values are expressed in median (IQR). Mann‐Whitney test P‐value reported (*P < .05). IPSS‐QoL corresponds to IPSS question number 8. IIEF‐15 domains
| FU group (n = 15) | PT group (n = 9) | P | |
|---|---|---|---|
| Ultrasound | |||
| PV (mL) | 41.3 (31.6;62.8) | 42.0 (34.3;70.1) | 0.640 |
| Adenome volume (mL) | 11.6 (8.9;23.6) | 13.3 (12.5;38.0) | 0.108 |
| LUTS questionnaire | |||
| IPSS | 9.0 (6.0;14.0) | 8.0 (6.0;14.5) | 0.770 |
| IPSS‐QoL | 2.0 (1.0;3.0) | 1.0 (1.0;2.0) | 0.446 |
| Sexual function questionnaire (IIEF‐15) | |||
| EF | 28.0 (23.0;30.0) | 23.0 (15.0;27.0) | 0.073 |
| IS | 10.0 (9.0;12.0) | 10.0 (4.5;12.5) | 0.815 |
| SD | 8.0 (7.0;9.0) | 7.0 (6.0;8.0) | 0.123 |
| OF | 9.0 (6.0;10.0) | 10.0 (9.0;11.0) | 0.084 |
| OS | 8.0 (4.0;10.0) | 8.0 (6.0;9.0) | 0.861 |
| Hormones | |||
| FSH (mUI/mL) | 8.7 (5.2;14.0) | 5.0 (4.4;9.0) | 0.174 |
| LH (mUI/mL) | 5.3 (3.5;7.2) | 3.3 (2.7;5.0) | 0.104 |
| Testosterone (nmol/L) | 16.1 (13.4;21.7) | 14.2 (10.9;16.4) | 0.121 |
| Estradiol (pg/mL) | 20.6 (16.6;23.9) | 20.5 (16.4;28.6) | 0.097 |
| Lipid and glucose metabolism | |||
| Glycemia (mg/dL) | 102.6 (90.0;113.4) | 95.4 (90.4;103.5) | 0.392 |
| HbA1c (%) | 5.6 (5.3;6.3) | 5.5 (5.3;5.7) | 0.558 |
| Total cholesterol (mg/dL) | 174.4 (158.5; 224.3) | 182.5 (146.4;204.2) | 0.682 |
| HDL (mg/dL) | 49.1 (43.3;57.2) | 52.2 (44.3; 63.8) | 0.411 |
| LDL (mg/dL) | 110.5 (85.1;132.6) | 96.7 (78.3;127.2) | 0.599 |
| Triglycerides (mg/dL) | 95.6 (83.2; 157.6) | 81.4 (66.4;152.7) | 0.318 |
| Kidney function | |||
| Creatinine (mg/dL) | 0.9 (0.9;1.2) | 1.0 (0.9;1.2) | 0.861 |
| Urea (mg/dL) | 33.0 (30.0;46.8) | 39.0 (30.6;41.7) | 0.815 |
| Inflammation markers | |||
| WBCs (×109/L) | 7.0 (5.4;8.5) | 7.0 (4.6;7.7) | 0.548 |
| Neutrophils (×109/L) | 4.0 (3.0;4.9) | 3.7 (2.9;5.0) | 0.925 |
| Lymphocytes (×109/L) | 1.8 (1.5;2.3) | 1.8 (1.2;2.6) | 0.875 |
| ESR (mm/h) | 7.0 (4.0‐10.0) | 3.0 (2.5;7.5) | 0.155 |
| CRP (μg/L) | 1500 (600‐2300) | 800 (600‐1700) | 0.446 |
| Fibrinogen (g/L) | 3.1 (2.9‐3.6) | 2.6 (2.5;3.3) | 0.155 |
| PSA (ng/mL) | 2.1 (0.9;3.2) | 4.9 (0.9;7.2) | 0.165 |
Abbreviations: EF, erectile function; IS, intercourse satisfaction; OF, orgasmic function; OS, overall satisfaction; SD, sexual desire.